View Financial HealthNational Oxygen 배당 및 자사주 매입배당 기준 점검 0/6National Oxygen 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesReported Earnings • May 26Full year 2026 earnings released: EPS: ₹3.64 (vs ₹13.89 loss in FY 2025)Full year 2026 results: EPS: ₹3.64 (up from ₹13.89 loss in FY 2025). Revenue: ₹237.2m (down 42% from FY 2025). Net income: ₹18.4m (up ₹88.4m from FY 2025). Profit margin: 7.7% (up from net loss in FY 2025). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.공시 • May 19National Oxygen Limited to Report Q4, 2026 Results on May 25, 2026National Oxygen Limited announced that they will report Q4, 2026 results on May 25, 2026Valuation Update With 7 Day Price Move • May 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹81.98, the stock trades at a trailing P/E ratio of 40.4x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 7.7% over the past three years.Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹67.42, the stock trades at a trailing P/E ratio of 33.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 27% over the past three years.공시 • Mar 21National Oxygen Limited announced that it expects to receive funding from Saraf Housing Development Private LimitedNational Oxygen Limited announced a private placement to issue 950,000 shares on March 20, 2026. The transaction will include participation from new investor Saraf Housing Development Private Limited. The transaction has been approved by shareholders of company.Reported Earnings • Jan 31Third quarter 2026 earnings released: ₹3.08 loss per share (vs ₹3.92 loss in 3Q 2025)Third quarter 2026 results: ₹3.08 loss per share (improved from ₹3.92 loss in 3Q 2025). Revenue: ₹51.5m (down 52% from 3Q 2025). Net loss: ₹15.5m (loss narrowed 21% from 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.공시 • Jan 27National Oxygen Limited to Report Q3, 2026 Results on Jan 30, 2026National Oxygen Limited announced that they will report Q3, 2026 results on Jan 30, 2026Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹93.46, the stock trades at a trailing P/E ratio of 78.5x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 39% over the past three years.New Risk • Jan 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-₹28m). Market cap is less than US$10m (₹449.3m market cap, or US$4.99m). Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Large one-off items impacting financial results. Revenue is less than US$5m (₹334m revenue, or US$3.7m).Valuation Update With 7 Day Price Move • Dec 23Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹78.65, the stock trades at a trailing P/E ratio of 66x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 54% over the past three years.Valuation Update With 7 Day Price Move • Dec 08Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹95.00, the stock trades at a trailing P/E ratio of 79.7x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 26% over the past three years.Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: ₹13.96 (vs ₹2.35 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹13.96 (up from ₹2.35 loss in 2Q 2025). Revenue: ₹66.2m (down 38% from 2Q 2025). Net income: ₹70.4m (up ₹82.3m from 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.공시 • Nov 07National Oxygen Limited to Report Q2, 2026 Results on Nov 12, 2025National Oxygen Limited announced that they will report Q2, 2026 results on Nov 12, 2025공시 • Aug 29National Oxygen Limited, Annual General Meeting, Sep 24, 2025National Oxygen Limited, Annual General Meeting, Sep 24, 2025, at 11:30 Indian Standard Time.New Risk • Aug 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹3.7m free cash flow). Negative equity (-₹80m). Earnings have declined by 40% per year over the past 5 years. Market cap is less than US$10m (₹634.1m market cap, or US$7.27m). Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Revenue is less than US$5m (₹376m revenue, or US$4.3m).Reported Earnings • Aug 08First quarter 2026 earnings released: ₹3.71 loss per share (vs ₹2.47 loss in 1Q 2025)First quarter 2026 results: ₹3.71 loss per share (further deteriorated from ₹2.47 loss in 1Q 2025). Revenue: ₹76.4m (down 28% from 1Q 2025). Net loss: ₹18.7m (loss widened 50% from 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance.공시 • Aug 05National Oxygen Limited to Report Q1, 2026 Results on Aug 07, 2025National Oxygen Limited announced that they will report Q1, 2026 results on Aug 07, 2025Reported Earnings • May 31Full year 2025 earnings released: ₹13.90 loss per share (vs ₹6.41 loss in FY 2024)Full year 2025 results: ₹13.90 loss per share (further deteriorated from ₹6.41 loss in FY 2024). Revenue: ₹408.6m (down 9.7% from FY 2024). Net loss: ₹70.0m (loss widened 117% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 120 percentage points per year, which is a significant difference in performance.공시 • May 26National Oxygen Limited to Report Q4, 2025 Results on May 29, 2025National Oxygen Limited announced that they will report Q4, 2025 results on May 29, 2025Reported Earnings • Feb 08Third quarter 2025 earnings released: ₹3.92 loss per share (vs ₹2.52 loss in 3Q 2024)Third quarter 2025 results: ₹3.92 loss per share (further deteriorated from ₹2.52 loss in 3Q 2024). Revenue: ₹108.5m (down 4.0% from 3Q 2024). Net loss: ₹19.8m (loss widened 63% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 126 percentage points per year, which is a significant difference in performance.New Risk • Feb 03New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₹435m (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹34m). Earnings have declined by 15% per year over the past 5 years. Market cap is less than US$10m (₹607.9m market cap, or US$6.98m). Minor Risk Revenue is less than US$5m (₹435m revenue, or US$5.0m).공시 • Jan 29National Oxygen Limited to Report Q3, 2025 Results on Feb 07, 2025National Oxygen Limited announced that they will report Q3, 2025 results on Feb 07, 2025Reported Earnings • Nov 13Second quarter 2025 earnings released: ₹2.35 loss per share (vs ₹1.26 loss in 2Q 2024)Second quarter 2025 results: ₹2.35 loss per share (further deteriorated from ₹1.26 loss in 2Q 2024). Revenue: ₹106.9m (down 9.5% from 2Q 2024). Net loss: ₹11.9m (loss widened 97% from 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 151 percentage points per year, which is a significant difference in performance.공시 • Nov 09National Oxygen Limited to Report Q2, 2025 Results on Nov 11, 2024National Oxygen Limited announced that they will report Q2, 2025 results on Nov 11, 2024Reported Earnings • Aug 14First quarter 2025 earnings released: ₹2.47 loss per share (vs ₹1.21 loss in 1Q 2024)First quarter 2025 results: ₹2.47 loss per share (further deteriorated from ₹1.21 loss in 1Q 2024). Revenue: ₹106.3m (down 4.4% from 1Q 2024). Net loss: ₹12.5m (loss widened 115% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 143 percentage points per year, which is a significant difference in performance.공시 • Aug 13National Oxygen Limited, Annual General Meeting, Sep 16, 2024National Oxygen Limited, Annual General Meeting, Sep 16, 2024.공시 • Aug 02National Oxygen Limited to Report Q1, 2025 Results on Aug 13, 2024National Oxygen Limited announced that they will report Q1, 2025 results on Aug 13, 2024Reported Earnings • May 23Full year 2024 earnings released: ₹6.60 loss per share (vs ₹1.65 loss in FY 2023)Full year 2024 results: ₹6.60 loss per share (further deteriorated from ₹1.65 loss in FY 2023). Revenue: ₹457.6m (down 2.9% from FY 2023). Net loss: ₹32.3m (loss widened 309% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 122 percentage points per year, which is a significant difference in performance.New Risk • May 21New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-₹21m). Earnings have declined by 1.5% per year over the past 5 years. Market cap is less than US$10m (₹816.6m market cap, or US$9.80m). Minor Risk Shareholders have been diluted in the past year (5.0% increase in shares outstanding).공시 • May 15National Oxygen Limited to Report Q4, 2024 Results on May 22, 2024National Oxygen Limited announced that they will report Q4, 2024 results on May 22, 2024New Risk • Apr 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹21m). Earnings have declined by 1.5% per year over the past 5 years. Market cap is less than US$10m (₹673.8m market cap, or US$8.07m). Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change).공시 • Feb 03National Oxygen Limited to Report Q3, 2024 Results on Feb 09, 2024National Oxygen Limited announced that they will report Q3, 2024 results on Feb 09, 2024공시 • Jan 22National Oxygen Limited announced that it expects to receive funding from Saraf Housing Development Private LimitedNational Oxygen Limited announced a private placement of 240,114 common shares on January 20, 2024. The transaction included participation from new investor Saraf Housing Development Private Limited. The transaction has been approved by the board of directors of the company.Reported Earnings • Nov 09Second quarter 2024 earnings released: ₹1.26 loss per share (vs ₹2.43 loss in 2Q 2023)Second quarter 2024 results: ₹1.26 loss per share (improved from ₹2.43 loss in 2Q 2023). Revenue: ₹119.3m (up 1.6% from 2Q 2023). Net loss: ₹6.03m (loss narrowed 48% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 38% per year, which means it is well ahead of earnings.New Risk • Aug 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹9.3m). Market cap is less than US$10m (₹587.3m market cap, or US$7.07m). Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).Reported Earnings • Aug 06Full year 2023 earnings released: ₹1.65 loss per share (vs ₹15.88 profit in FY 2022)Full year 2023 results: ₹1.65 loss per share (down from ₹15.88 profit in FY 2022). Revenue: ₹471.1m (down 6.9% from FY 2022). Net loss: ₹7.91m (down 110% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.공시 • Aug 04National Oxygen Limited to Report Q1, 2024 Results on Aug 11, 2023National Oxygen Limited announced that they will report Q1, 2024 results on Aug 11, 2023공시 • Aug 03National Oxygen Limited, Annual General Meeting, Aug 28, 2023National Oxygen Limited, Annual General Meeting, Aug 28, 2023, at 11:30 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023 together with the Reports of the Board of Directors and the Auditors thereon; to appoint a director in place of Ms. Sarita Saraf who retires from office by rotation and being eligible offers herself for reappointment; to reappoint Ms. Mona Milan Parekh as independent director of the company for a second term of five consecutive year to reappoint Mr. Rajesh Kumar Saraf as independent director of the company for a second term of five consecutive year; and to consider other matters.Reported Earnings • May 30Full year 2023 earnings released: ₹1.65 loss per share (vs ₹15.88 profit in FY 2022)Full year 2023 results: ₹1.65 loss per share (down from ₹15.88 profit in FY 2022). Revenue: ₹477.0m (down 6.1% from FY 2022). Net loss: ₹7.91m (down 110% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 46% per year whereas the company’s share price has increased by 48% per year.공시 • May 19National Oxygen Limited to Report Q4, 2023 Results on May 24, 2023National Oxygen Limited announced that they will report Q4, 2023 results at 3:30 PM, Indian Standard Time on May 24, 2023Board Change • Apr 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Director Amit Agarwal was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 06Third quarter 2023 earnings released: ₹1.00 loss per share (vs ₹1.44 profit in 3Q 2022)Third quarter 2023 results: ₹1.00 loss per share (down from ₹1.44 profit in 3Q 2022). Revenue: ₹119.2m (flat on 3Q 2022). Net loss: ₹4.83m (down 170% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 52% per year, which means it is significantly lagging earnings growth.공시 • Jan 26National Oxygen Limited to Report Q3, 2023 Results on Feb 03, 2023National Oxygen Limited announced that they will report Q3, 2023 results on Feb 03, 2023Reported Earnings • Nov 05Second quarter 2023 earnings released: ₹2.43 loss per share (vs ₹4.00 profit in 2Q 2022)Second quarter 2023 results: ₹2.43 loss per share (down from ₹4.00 profit in 2Q 2022). Revenue: ₹117.7m (down 11% from 2Q 2022). Net loss: ₹11.7m (down 161% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 40% per year, which means it is significantly lagging earnings growth.공시 • Oct 27National Oxygen Limited to Report First Half, 2022 Results on Nov 04, 2022National Oxygen Limited announced that they will report first half, 2022 results on Nov 04, 2022Reported Earnings • Jul 26First quarter 2023 earnings released: EPS: ₹0.04 (vs ₹8.40 in 1Q 2022)First quarter 2023 results: EPS: ₹0.04 (down from ₹8.40 in 1Q 2022). Revenue: ₹114.2m (down 21% from 1Q 2022). Net income: ₹170.0k (down 100% from 1Q 2022). Profit margin: 0.1% (down from 28% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth.공시 • Jul 26National Oxygen Limited, Annual General Meeting, Aug 30, 2022National Oxygen Limited, Annual General Meeting, Aug 30, 2022. Agenda: To discuss the re-appointment of independent director for the second term of five years; to discuss the issue of equity shares on preferential basis to promoter group company alterations of memorandum of association; to discuss the related party transactions; to discuss the directors report and the audit report; and to discuss other matters.공시 • Jul 15National Oxygen Limited to Report Q1, 2023 Results on Jul 25, 2022National Oxygen Limited announced that they will report Q1, 2023 results at 12:15 PM, Indian Standard Time on Jul 25, 2022Valuation Update With 7 Day Price Move • Jul 11Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹114, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 182% over the past three years.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹108, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 167% over the past three years.공시 • May 23National Oxygen Limited Appoints Sarita Saraff as Marketing HeadNational Oxygen Limited appointed Sarita Saraff as Marketing Head at the Board Meeting held on May 21, 2022.Reported Earnings • May 22Full year 2022 earnings released: EPS: ₹15.88 (vs ₹2.28 loss in FY 2021)Full year 2022 results: EPS: ₹15.88 (up from ₹2.28 loss in FY 2021). Revenue: ₹520.5m (up 30% from FY 2021). Net income: ₹76.3m (up ₹87.2m from FY 2021). Profit margin: 15% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 40% per year, which means it is significantly lagging earnings growth.공시 • May 14National Oxygen Limited to Report Q4, 2022 Results on May 21, 2022National Oxygen Limited announced that they will report Q4, 2022 results on May 21, 2022Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹115, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 211% over the past three years.Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₹100, the stock trades at a trailing P/E ratio of 6.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 160% over the past three years.Valuation Update With 7 Day Price Move • Mar 02Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹70.45, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 86% over the past three years.Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.44 (down from ₹2.94 in 3Q 2021). Revenue: ₹118.8m (down 5.8% from 3Q 2021). Net income: ₹6.93m (down 51% from 3Q 2021). Profit margin: 5.8% (down from 11% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Feb 11Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹118, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 219% over the past three years.Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹128, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 226% over the past three years.Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹75.80, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 74% over the past three years.Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹65.10, the stock trades at a trailing P/E ratio of 6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 243% over the past three years.Reported Earnings • Aug 15First quarter 2022 earnings released: EPS ₹8.40 (vs ₹4.77 loss in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹145.1m (up 120% from 1Q 2021). Net income: ₹40.3m (up ₹63.2m from 1Q 2021). Profit margin: 28% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has increased by 45% per year, which means it is well ahead of earnings.Reported Earnings • Feb 10Third quarter 2021 earnings released: EPS ₹2.94 (vs ₹1.34 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹126.4m (up 15% from 3Q 2020). Net income: ₹14.1m (up ₹20.5m from 3Q 2020). Profit margin: 11% (up from net loss in 3Q 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 63% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.공시 • Feb 04National Oxygen Limited to Report Q3, 2021 Results on Feb 09, 2021National Oxygen Limited announced that they will report Q3, 2021 results on Feb 09, 2021Is New 90 Day High Low • Jan 28New 90-day high: ₹46.50The company is up 21% from its price of ₹38.35 on 26 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.Is New 90 Day High Low • Dec 02New 90-day low: ₹36.00The company is down 9.0% from its price of ₹39.50 on 03 September 2020. The Indian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.Reported Earnings • Nov 12Second quarter 2021 earnings released: ₹2.53 loss per shareThe company reported a poor second quarter result with weaker earnings, revenues and control over expenses. Second quarter 2021 results: Revenue: ₹90.6m (down 22% from 2Q 2020). Net loss: ₹12.2m (down ₹13.3m from profit in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Is New 90 Day High Low • Sep 18New 90-day high: ₹43.55The company is up 20% from its price of ₹36.15 on 19 June 2020. The Indian market is up 14% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 21% over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 507813 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 507813 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장National Oxygen 배당 수익률 vs 시장507813의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (507813)n/a시장 하위 25% (IN)0.3%시장 상위 25% (IN)1.5%업계 평균 (Chemicals)0.8%분석가 예측 (507813) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 507813 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 507813 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 507813 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: 507813 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/10 01:56종가2026/06/10 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스National Oxygen Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • May 26Full year 2026 earnings released: EPS: ₹3.64 (vs ₹13.89 loss in FY 2025)Full year 2026 results: EPS: ₹3.64 (up from ₹13.89 loss in FY 2025). Revenue: ₹237.2m (down 42% from FY 2025). Net income: ₹18.4m (up ₹88.4m from FY 2025). Profit margin: 7.7% (up from net loss in FY 2025). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
공시 • May 19National Oxygen Limited to Report Q4, 2026 Results on May 25, 2026National Oxygen Limited announced that they will report Q4, 2026 results on May 25, 2026
Valuation Update With 7 Day Price Move • May 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹81.98, the stock trades at a trailing P/E ratio of 40.4x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 7.7% over the past three years.
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹67.42, the stock trades at a trailing P/E ratio of 33.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 27% over the past three years.
공시 • Mar 21National Oxygen Limited announced that it expects to receive funding from Saraf Housing Development Private LimitedNational Oxygen Limited announced a private placement to issue 950,000 shares on March 20, 2026. The transaction will include participation from new investor Saraf Housing Development Private Limited. The transaction has been approved by shareholders of company.
Reported Earnings • Jan 31Third quarter 2026 earnings released: ₹3.08 loss per share (vs ₹3.92 loss in 3Q 2025)Third quarter 2026 results: ₹3.08 loss per share (improved from ₹3.92 loss in 3Q 2025). Revenue: ₹51.5m (down 52% from 3Q 2025). Net loss: ₹15.5m (loss narrowed 21% from 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
공시 • Jan 27National Oxygen Limited to Report Q3, 2026 Results on Jan 30, 2026National Oxygen Limited announced that they will report Q3, 2026 results on Jan 30, 2026
Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹93.46, the stock trades at a trailing P/E ratio of 78.5x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 39% over the past three years.
New Risk • Jan 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-₹28m). Market cap is less than US$10m (₹449.3m market cap, or US$4.99m). Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Large one-off items impacting financial results. Revenue is less than US$5m (₹334m revenue, or US$3.7m).
Valuation Update With 7 Day Price Move • Dec 23Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹78.65, the stock trades at a trailing P/E ratio of 66x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 54% over the past three years.
Valuation Update With 7 Day Price Move • Dec 08Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹95.00, the stock trades at a trailing P/E ratio of 79.7x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 26% over the past three years.
Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: ₹13.96 (vs ₹2.35 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹13.96 (up from ₹2.35 loss in 2Q 2025). Revenue: ₹66.2m (down 38% from 2Q 2025). Net income: ₹70.4m (up ₹82.3m from 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
공시 • Nov 07National Oxygen Limited to Report Q2, 2026 Results on Nov 12, 2025National Oxygen Limited announced that they will report Q2, 2026 results on Nov 12, 2025
공시 • Aug 29National Oxygen Limited, Annual General Meeting, Sep 24, 2025National Oxygen Limited, Annual General Meeting, Sep 24, 2025, at 11:30 Indian Standard Time.
New Risk • Aug 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹3.7m free cash flow). Negative equity (-₹80m). Earnings have declined by 40% per year over the past 5 years. Market cap is less than US$10m (₹634.1m market cap, or US$7.27m). Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Revenue is less than US$5m (₹376m revenue, or US$4.3m).
Reported Earnings • Aug 08First quarter 2026 earnings released: ₹3.71 loss per share (vs ₹2.47 loss in 1Q 2025)First quarter 2026 results: ₹3.71 loss per share (further deteriorated from ₹2.47 loss in 1Q 2025). Revenue: ₹76.4m (down 28% from 1Q 2025). Net loss: ₹18.7m (loss widened 50% from 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance.
공시 • Aug 05National Oxygen Limited to Report Q1, 2026 Results on Aug 07, 2025National Oxygen Limited announced that they will report Q1, 2026 results on Aug 07, 2025
Reported Earnings • May 31Full year 2025 earnings released: ₹13.90 loss per share (vs ₹6.41 loss in FY 2024)Full year 2025 results: ₹13.90 loss per share (further deteriorated from ₹6.41 loss in FY 2024). Revenue: ₹408.6m (down 9.7% from FY 2024). Net loss: ₹70.0m (loss widened 117% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 120 percentage points per year, which is a significant difference in performance.
공시 • May 26National Oxygen Limited to Report Q4, 2025 Results on May 29, 2025National Oxygen Limited announced that they will report Q4, 2025 results on May 29, 2025
Reported Earnings • Feb 08Third quarter 2025 earnings released: ₹3.92 loss per share (vs ₹2.52 loss in 3Q 2024)Third quarter 2025 results: ₹3.92 loss per share (further deteriorated from ₹2.52 loss in 3Q 2024). Revenue: ₹108.5m (down 4.0% from 3Q 2024). Net loss: ₹19.8m (loss widened 63% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 126 percentage points per year, which is a significant difference in performance.
New Risk • Feb 03New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₹435m (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹34m). Earnings have declined by 15% per year over the past 5 years. Market cap is less than US$10m (₹607.9m market cap, or US$6.98m). Minor Risk Revenue is less than US$5m (₹435m revenue, or US$5.0m).
공시 • Jan 29National Oxygen Limited to Report Q3, 2025 Results on Feb 07, 2025National Oxygen Limited announced that they will report Q3, 2025 results on Feb 07, 2025
Reported Earnings • Nov 13Second quarter 2025 earnings released: ₹2.35 loss per share (vs ₹1.26 loss in 2Q 2024)Second quarter 2025 results: ₹2.35 loss per share (further deteriorated from ₹1.26 loss in 2Q 2024). Revenue: ₹106.9m (down 9.5% from 2Q 2024). Net loss: ₹11.9m (loss widened 97% from 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 151 percentage points per year, which is a significant difference in performance.
공시 • Nov 09National Oxygen Limited to Report Q2, 2025 Results on Nov 11, 2024National Oxygen Limited announced that they will report Q2, 2025 results on Nov 11, 2024
Reported Earnings • Aug 14First quarter 2025 earnings released: ₹2.47 loss per share (vs ₹1.21 loss in 1Q 2024)First quarter 2025 results: ₹2.47 loss per share (further deteriorated from ₹1.21 loss in 1Q 2024). Revenue: ₹106.3m (down 4.4% from 1Q 2024). Net loss: ₹12.5m (loss widened 115% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 143 percentage points per year, which is a significant difference in performance.
공시 • Aug 13National Oxygen Limited, Annual General Meeting, Sep 16, 2024National Oxygen Limited, Annual General Meeting, Sep 16, 2024.
공시 • Aug 02National Oxygen Limited to Report Q1, 2025 Results on Aug 13, 2024National Oxygen Limited announced that they will report Q1, 2025 results on Aug 13, 2024
Reported Earnings • May 23Full year 2024 earnings released: ₹6.60 loss per share (vs ₹1.65 loss in FY 2023)Full year 2024 results: ₹6.60 loss per share (further deteriorated from ₹1.65 loss in FY 2023). Revenue: ₹457.6m (down 2.9% from FY 2023). Net loss: ₹32.3m (loss widened 309% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 122 percentage points per year, which is a significant difference in performance.
New Risk • May 21New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-₹21m). Earnings have declined by 1.5% per year over the past 5 years. Market cap is less than US$10m (₹816.6m market cap, or US$9.80m). Minor Risk Shareholders have been diluted in the past year (5.0% increase in shares outstanding).
공시 • May 15National Oxygen Limited to Report Q4, 2024 Results on May 22, 2024National Oxygen Limited announced that they will report Q4, 2024 results on May 22, 2024
New Risk • Apr 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹21m). Earnings have declined by 1.5% per year over the past 5 years. Market cap is less than US$10m (₹673.8m market cap, or US$8.07m). Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change).
공시 • Feb 03National Oxygen Limited to Report Q3, 2024 Results on Feb 09, 2024National Oxygen Limited announced that they will report Q3, 2024 results on Feb 09, 2024
공시 • Jan 22National Oxygen Limited announced that it expects to receive funding from Saraf Housing Development Private LimitedNational Oxygen Limited announced a private placement of 240,114 common shares on January 20, 2024. The transaction included participation from new investor Saraf Housing Development Private Limited. The transaction has been approved by the board of directors of the company.
Reported Earnings • Nov 09Second quarter 2024 earnings released: ₹1.26 loss per share (vs ₹2.43 loss in 2Q 2023)Second quarter 2024 results: ₹1.26 loss per share (improved from ₹2.43 loss in 2Q 2023). Revenue: ₹119.3m (up 1.6% from 2Q 2023). Net loss: ₹6.03m (loss narrowed 48% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 38% per year, which means it is well ahead of earnings.
New Risk • Aug 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹9.3m). Market cap is less than US$10m (₹587.3m market cap, or US$7.07m). Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).
Reported Earnings • Aug 06Full year 2023 earnings released: ₹1.65 loss per share (vs ₹15.88 profit in FY 2022)Full year 2023 results: ₹1.65 loss per share (down from ₹15.88 profit in FY 2022). Revenue: ₹471.1m (down 6.9% from FY 2022). Net loss: ₹7.91m (down 110% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.
공시 • Aug 04National Oxygen Limited to Report Q1, 2024 Results on Aug 11, 2023National Oxygen Limited announced that they will report Q1, 2024 results on Aug 11, 2023
공시 • Aug 03National Oxygen Limited, Annual General Meeting, Aug 28, 2023National Oxygen Limited, Annual General Meeting, Aug 28, 2023, at 11:30 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023 together with the Reports of the Board of Directors and the Auditors thereon; to appoint a director in place of Ms. Sarita Saraf who retires from office by rotation and being eligible offers herself for reappointment; to reappoint Ms. Mona Milan Parekh as independent director of the company for a second term of five consecutive year to reappoint Mr. Rajesh Kumar Saraf as independent director of the company for a second term of five consecutive year; and to consider other matters.
Reported Earnings • May 30Full year 2023 earnings released: ₹1.65 loss per share (vs ₹15.88 profit in FY 2022)Full year 2023 results: ₹1.65 loss per share (down from ₹15.88 profit in FY 2022). Revenue: ₹477.0m (down 6.1% from FY 2022). Net loss: ₹7.91m (down 110% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 46% per year whereas the company’s share price has increased by 48% per year.
공시 • May 19National Oxygen Limited to Report Q4, 2023 Results on May 24, 2023National Oxygen Limited announced that they will report Q4, 2023 results at 3:30 PM, Indian Standard Time on May 24, 2023
Board Change • Apr 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Director Amit Agarwal was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 06Third quarter 2023 earnings released: ₹1.00 loss per share (vs ₹1.44 profit in 3Q 2022)Third quarter 2023 results: ₹1.00 loss per share (down from ₹1.44 profit in 3Q 2022). Revenue: ₹119.2m (flat on 3Q 2022). Net loss: ₹4.83m (down 170% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 52% per year, which means it is significantly lagging earnings growth.
공시 • Jan 26National Oxygen Limited to Report Q3, 2023 Results on Feb 03, 2023National Oxygen Limited announced that they will report Q3, 2023 results on Feb 03, 2023
Reported Earnings • Nov 05Second quarter 2023 earnings released: ₹2.43 loss per share (vs ₹4.00 profit in 2Q 2022)Second quarter 2023 results: ₹2.43 loss per share (down from ₹4.00 profit in 2Q 2022). Revenue: ₹117.7m (down 11% from 2Q 2022). Net loss: ₹11.7m (down 161% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 40% per year, which means it is significantly lagging earnings growth.
공시 • Oct 27National Oxygen Limited to Report First Half, 2022 Results on Nov 04, 2022National Oxygen Limited announced that they will report first half, 2022 results on Nov 04, 2022
Reported Earnings • Jul 26First quarter 2023 earnings released: EPS: ₹0.04 (vs ₹8.40 in 1Q 2022)First quarter 2023 results: EPS: ₹0.04 (down from ₹8.40 in 1Q 2022). Revenue: ₹114.2m (down 21% from 1Q 2022). Net income: ₹170.0k (down 100% from 1Q 2022). Profit margin: 0.1% (down from 28% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth.
공시 • Jul 26National Oxygen Limited, Annual General Meeting, Aug 30, 2022National Oxygen Limited, Annual General Meeting, Aug 30, 2022. Agenda: To discuss the re-appointment of independent director for the second term of five years; to discuss the issue of equity shares on preferential basis to promoter group company alterations of memorandum of association; to discuss the related party transactions; to discuss the directors report and the audit report; and to discuss other matters.
공시 • Jul 15National Oxygen Limited to Report Q1, 2023 Results on Jul 25, 2022National Oxygen Limited announced that they will report Q1, 2023 results at 12:15 PM, Indian Standard Time on Jul 25, 2022
Valuation Update With 7 Day Price Move • Jul 11Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹114, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 182% over the past three years.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹108, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 167% over the past three years.
공시 • May 23National Oxygen Limited Appoints Sarita Saraff as Marketing HeadNational Oxygen Limited appointed Sarita Saraff as Marketing Head at the Board Meeting held on May 21, 2022.
Reported Earnings • May 22Full year 2022 earnings released: EPS: ₹15.88 (vs ₹2.28 loss in FY 2021)Full year 2022 results: EPS: ₹15.88 (up from ₹2.28 loss in FY 2021). Revenue: ₹520.5m (up 30% from FY 2021). Net income: ₹76.3m (up ₹87.2m from FY 2021). Profit margin: 15% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 40% per year, which means it is significantly lagging earnings growth.
공시 • May 14National Oxygen Limited to Report Q4, 2022 Results on May 21, 2022National Oxygen Limited announced that they will report Q4, 2022 results on May 21, 2022
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹115, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 211% over the past three years.
Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₹100, the stock trades at a trailing P/E ratio of 6.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 160% over the past three years.
Valuation Update With 7 Day Price Move • Mar 02Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹70.45, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 86% over the past three years.
Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.44 (down from ₹2.94 in 3Q 2021). Revenue: ₹118.8m (down 5.8% from 3Q 2021). Net income: ₹6.93m (down 51% from 3Q 2021). Profit margin: 5.8% (down from 11% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Feb 11Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹118, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 219% over the past three years.
Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹128, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 226% over the past three years.
Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹75.80, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 74% over the past three years.
Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹65.10, the stock trades at a trailing P/E ratio of 6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 243% over the past three years.
Reported Earnings • Aug 15First quarter 2022 earnings released: EPS ₹8.40 (vs ₹4.77 loss in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹145.1m (up 120% from 1Q 2021). Net income: ₹40.3m (up ₹63.2m from 1Q 2021). Profit margin: 28% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has increased by 45% per year, which means it is well ahead of earnings.
Reported Earnings • Feb 10Third quarter 2021 earnings released: EPS ₹2.94 (vs ₹1.34 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹126.4m (up 15% from 3Q 2020). Net income: ₹14.1m (up ₹20.5m from 3Q 2020). Profit margin: 11% (up from net loss in 3Q 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 63% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
공시 • Feb 04National Oxygen Limited to Report Q3, 2021 Results on Feb 09, 2021National Oxygen Limited announced that they will report Q3, 2021 results on Feb 09, 2021
Is New 90 Day High Low • Jan 28New 90-day high: ₹46.50The company is up 21% from its price of ₹38.35 on 26 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
Is New 90 Day High Low • Dec 02New 90-day low: ₹36.00The company is down 9.0% from its price of ₹39.50 on 03 September 2020. The Indian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
Reported Earnings • Nov 12Second quarter 2021 earnings released: ₹2.53 loss per shareThe company reported a poor second quarter result with weaker earnings, revenues and control over expenses. Second quarter 2021 results: Revenue: ₹90.6m (down 22% from 2Q 2020). Net loss: ₹12.2m (down ₹13.3m from profit in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Is New 90 Day High Low • Sep 18New 90-day high: ₹43.55The company is up 20% from its price of ₹36.15 on 19 June 2020. The Indian market is up 14% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 21% over the same period.